Corticosteroids directly reduce Staphylococcus aureus biofilm growth: An in vitro study
- 2 October 2013
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 124 (3) , 602-607
Abstract
Objectives/Hypothesis: Clinical improvement in patients with chronic rhinosinusitis (CRS) treated with steroids alone has previously been ascribed to the steroids' anti‐inflammatory properties rather than any direct effect on the bacteria. The aim of this study was to determine if commonly used intranasal steroids directly reduce bacterial biofilm production in vitro.Study Design: In vitro comparative controlled trial.Methods: Staphylococcus aureus biofilms were grown on minimum biofilm eradication concentration device pegs and treated with the commonly prescribed CRS topical steroids fluticasone, mometasone, or budesonide. These were dissolved in vehicle solvents and added to cerebrospinal fluid (CSF) broth. Concentrations (including therapeutic doses) tested for fluticasone and mometasone ranged from 25 μg/200 μL to 400 μg/200 μL, and from 16 μg/200 μL to 2000 μg/200 μL for budesonide. Control pegs were exposed to equivalent volumes of the appropriate solvent/CSF broth. Confocal scanning laser microscopy and COMSTAT software were used to quantify biofilms at 24 hours after treatment.Results: Significant differences from control were found for fluticasone at 400 μg/200 μL (difference = −0.3065 μm3/μm2, P = .007), mometasone at 300 μg/200 μL and 400 μg/200 μL (difference = −0.15 μm3/μm2, P = .006, and difference = −0.9193 μm3/μm2, P = .034, respectively), and budesonide at 750 μg/200 μL, 1000 μg/200 μL and 2000 μg/200 μL (difference = −1.0137 μm3/μm2, P = .038, difference = −0.6164, P = .009, and difference = −0.1906 μm3/μm2, P = .029, respectively).Conclusions: The concentrations of 400 μg/200 μL of fluticasone, 300 μg and 400 μg/200 μL of mometasone, and 750 μg, 1,000μg, and 2,000 μg/200 μL of budesonide directly reduce biofilm production in vitro, outside of the inflammatory milieu.Level of Evidence: NA. Laryngoscope, 124:602–607, 2014Keywords
This publication has 33 references indexed in Scilit:
- Effects of Dimethyl Sulfoxide in Cholesterol-Containing Lipid Membranes: A Comparative Study of Experiments In Silico and with CellsPLOS ONE, 2012
- Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2012
- Prevalence of Biofilms and Their Response to Medical Treatment in Chronic Rhinosinusitis without PolypsOtolaryngology–Head and Neck Surgery, 2012
- Factors affecting bacterial biofilm expression in chronic rhinosinusitis and the influences on prognosisAmerican Journal of Otolaryngology, 2011
- Chronic rhinosinusitis: Epidemiology and medical managementJournal of Allergy and Clinical Immunology, 2011
- Methylglyoxal‐infused honey mimics the anti‐Staphylococcus aureus biofilm activity of manuka honey: Potential Implication in Chronic RhinosinusitisThe Laryngoscope, 2011
- Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic reviewInternational Forum of Allergy & Rhinology, 2011
- Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implicationsAllergy, 2008
- Effect of Prednisolone on Cytokine Synthesis in Nasal PolypsJournal of Interferon & Cytokine Research, 1999
- Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps.Thorax, 1995